SURVODUTIDE

CAS NO.: 2805997-46-8
Molecular Formula: C192H289N47O61
Formula Weight: 4231.692
Purity: 98%
Appearance: White Powder

Function
1. Weight Loss:
Survodutide has shown promise in promoting weight loss by reducing appetite and enhancing energy expenditure.
2. Improved Glycemic Control:
It may help in regulating blood sugar levels, thereby improving glycemic control in individuals with type 2 diabetes.
3. Reduced Cardiovascular Risk:
By promoting weight loss and improving metabolic parameters, Survodutide may help lower the risk of cardiovascular diseases associated with obesity and diabetes.
4. Enhanced Insulin Sensitivity:
The peptide might improve insulin sensitivity, which is crucial for managing blood sugar levels effectively.
5. Regulate Blood Lipids:
Survodutide may help in improving lipid profiles, contributing to overall metabolic health.
6. Liver Protection:
It has a certain improvement effect on liver fat, inflammatory liver function and liver fibrosis

Description About Survodutide
Survodutide is a peptide that has been studied primarily for its potential benefits in the treatment of metabolic conditions, particularly obesity and type 2 diabetes.
Survodutide is a glucagon receptor/glucagon-like peptide-1 receptor (GCGR/GLP-1R) dual agonist. The GCGR agonist component can increase energy expenditure, directly act on the liver, and help improve liver fibrosis. The GLP-1R agonist component can reduce appetite and increase satiety.
The glucagon receptor agonist component in Survodutide can increase energy expenditure and directly affect the liver, which helps improve liver fibrosis. Its GLP-1 receptor agonist component can effectively reduce appetite and increase satiety. Studies have shown that Survodutide has significant benefits in the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH).